EUVIMEDEUVIMED entdecken
Crossref

Targeted molecular therapy (modified RIST regimen) in relapsed high risk stage IV neuroblastoma: two cases report

Paolo Indolfi, Selim Corbacioglu, Silverio Perrotta, Francesca Rossi, Antonio Marte, Elvira Pota, Martina Di Martino, Daniela Di Pinto, Cristiana Indolfi, Fiorina Casale

Theory and Clinical Practice in Pediatrics · 2018

DOI: 10.25082/tcpp.2018.01.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theory and Clinical Practice in Pediatrics, 2018. Verfasst von Paolo Indolfi und 9 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The prognosis for children with recurrent or refractory neuroblastoma remains a significant clinical challenge, and currently there are no known curative salvage regimens. In this paper we investigated the effect of imatinib with rapamycin and the chemotherapeutic agents temozolomide and irinotecan. We treated two children with recurrent neuroblastoma with this so called RIST protocol. Both patients, off therapy for 15 and 31 months, respectively are well, and developing normally, without any complications. These findings suggest that a combination regimen of RIST may provide a therapeutic benefit with a favorable toxicity profile to a unfortunate subset of patients with neuroblastoma.

Zitieren

APA

Indolfi, P., Corbacioglu, S., Perrotta, S., Rossi, F., Marte, A., Pota, E., Martino, M. D., Pinto, D. D., Indolfi, C., & Casale, F. (2018). Targeted molecular therapy (modified RIST regimen) in relapsed high risk stage IV neuroblastoma: two cases report. Theory and Clinical Practice in Pediatrics. https://doi.org/10.25082/tcpp.2018.01.002

Vancouver

Indolfi P, Corbacioglu S, Perrotta S, Rossi F, Marte A, Pota E, et al. Targeted molecular therapy (modified RIST regimen) in relapsed high risk stage IV neuroblastoma: two cases report. Theory and Clinical Practice in Pediatrics. 2018. doi:10.25082/tcpp.2018.01.002

BibTeX
@article{Indolfi2018,
  author = {Indolfi, Paolo and Corbacioglu, Selim and Perrotta, Silverio and Rossi, Francesca and Marte, Antonio and Pota, Elvira and Martino, Martina Di and Pinto, Daniela Di and Indolfi, Cristiana and Casale, Fiorina},
  title = {Targeted molecular therapy (modified RIST regimen) in relapsed high risk stage IV neuroblastoma: two cases report},
  journal = {Theory and Clinical Practice in Pediatrics},
  year = {2018},
  doi = {10.25082/tcpp.2018.01.002}
}
Kostenlos starten →